Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06138626 · ClinicalTrials.gov registry record · NA
Test of Excessive Anesthetic Fresh Gas Flow Alerting in the Electronic Medical Record to Reduce Excessive Fresh Gas Flow
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 336
- Enrollment target
NCT06138626: Completed NA study, sponsored by Stanford University.
NCT06138626 is a NA study that has completed, run by Stanford University. The registered enrollment target is 336 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06138626, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 336 participants
- Enrollment target
Study Summary
The primary objective of this quality improvement intervention is to test the efficacy of excessive fresh gas flow alerting in the electronic medical record for anesthesia providers.
Primary Outcome
Mean change in average total fresh gas flow, in liters per minute as recorded in the electronic medical record, when administering sevoflurane, averaged over 1 week at baseline and over 1 week at 90 days
Interventions
- BEHAVIORAL Alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 336 participants |
| Start Date | 2023-11-15 |
| Est. Completion | 2024-12-23 |
| Phase | NA |
What the finished NCT06138626 record still lists
NCT06138626 is an interventional study that assigns participants to a tested intervention. The registered 336 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 1 intervention - of which Alert is the first listed.
NCT06138626 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06138626 about?
NCT06138626 is a clinical study titled "Test of Excessive Anesthetic Fresh Gas Flow Alerting in the Electronic Medical Record to Reduce Excessive Fresh Gas Flow". The primary objective of this quality improvement intervention is to test the efficacy of excessive fresh gas flow alerting in the electronic medical record for anesthesia providers.
What is the current status of trial NCT06138626?
This trial is currently completed. It is a NA study. The enrollment target is 336 participants. The study started on 2023-11-15. Estimated completion is 2024-12-23.
What interventions are being tested in trial NCT06138626?
The interventions under investigation include: Alert (BEHAVIORAL).
Who is sponsoring clinical trial NCT06138626?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06138626's enrollment target sits among peer trials
336 305th of 2000 higher than 1,696 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03947385 · 336 participants · Phase 1
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- NCT03977207 · 336 participants · NA
A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
- NCT04665206 · 336 participants · Phase 1
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- NCT05124457 · 336 participants · Phase 2
DETERMINE: Detemir vs NPH
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI